Location: Mountain View, CA
CIK: 0001652044 · Show all filings
Period: Q4 2018 (← Previous) (Next →)
Filing Date: Nov 15, 2022
Total Value: $846M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| JD | JD com Inc | 13,553,474 | $284M | 33.5% | $38.95 | — | SPON ADR CL A | 47215P106 |
| — | Arris Intl Inc | 7,603,500 | $232M | 27.5% | $22.92 | — | SHS | G0551A103 |
| — | SVMK Inc | 4,608,705 | $56.55M | 6.7% | $16.03 | — | COM | 78489X103 |
| RCUS | Arcus Biosciences Inc | 5,049,786 | $54.39M | 6.4% | $16.66 | -29.9% | COM | 03969F109 |
| DOCU | DocuSign Inc | 1,171,284 | $46.95M | 5.6% | $50.48 | -16.8% | COM | 256163106 |
| ZS | Zscaler Inc | 1,189,688 | $46.65M | 5.5% | $29.28 | +29.0% | COM | 98980G102 |
| — | Forty Seven Inc | 1,545,966 | $24.3M | 2.9% | $16.00 | — | COM | 34983P104 |
| AUTL | Autolus Therapeutics PLC | 714,072 | $23.45M | 2.8% | $26.79 | — | SPON ADS | 05280R100 |
| — | Magenta Therapeutics Inc | 3,339,138 | $19.03M | 2.3% | $13.50 | — | COM | 55910K108 |
| SNAP | Snap Inc | 2,618,548 | $14.43M | 1.7% | $22.16 | -70.7% | CL A | 83304A106 |
| — | Gritstone Oncology Inc | 929,022 | $14.35M | 1.7% | $14.24 | — | COM | 39868T105 |
| — | Evelo Biosciences Inc | 1,060,495 | $13.8M | 1.6% | $11.80 | — | COM | 299734103 |
| SPRO | Spero Therapeutics Inc | 1,112,473 | $6.842M | 0.8% | $12.27 | -34.0% | COM | 84833T103 |
| — | Cloudera Inc | 427,710 | $4.73M | 0.6% | $16.02 | — | COM | 18914U100 |
| DXCM | Dexcom Inc | 110,457 | $3.266M | 0.4% | $31.72 | 0.0% | COM | 252131107 |
| XYZ | Square Inc | 12,342 | $692K | 0.1% | $70.61 | 0.0% | CL A | 852234103 |
| DBX | Dropbox Inc | 13,033 | $266K | 0.0% | $30.21 | -23.7% | CL A | 26210C104 |